ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.020
-0.020 (-1.92%)
At close: Jun 26, 2026, 4:00 PM EDT
1.049
+0.029 (2.79%)
After-hours: Jun 26, 2026, 7:00 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $129.73 million as of June 26, 2026. Its market cap has decreased by -62.94% in one year.
Market Cap
129.73M
Enterprise Value
334.99M
1-Year Change
-62.94%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $129.73M, a decrease of -93.65%. That is a compound annual growth rate of -36.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 129.73M | -70.33% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jyong Biotech | 139.56M |
| Connect Biopharma Holdings | 137.89M |
| TuHURA Biosciences | 137.55M |
| Enlivex | 137.40M |
| NRx Pharmaceuticals | 135.01M |
| Spero Therapeutics | 130.86M |
| Coya Therapeutics | 129.01M |
| Genelux | 127.45M |